FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198616971> ?p ?o ?g. }

• W3198616971 endingPage "325" @default.
• W3198616971 startingPage "317" @default.
• W3198616971 abstract "Objective To investigate the incidence of and factors associated with SARS–CoV‐2 testing and infection in immune‐mediated inflammatory disease (IMID) patients versus matched non‐IMID comparators from the general population. Methods We conducted a population‐based, matched cohort study among adult residents from Ontario, Canada, from January 2020 to December 2020. We created cohorts for the following IMIDs: rheumatoid arthritis (RA), psoriasis, psoriatic arthritis, ankylosing spondylitis, systemic autoimmune rheumatic diseases, multiple sclerosis (MS), iritis, inflammatory bowel disease (IBD), polymyalgia rheumatica, and vasculitis. Each patient was matched with 5 patients without IMIDs based on sociodemographic factors. We estimated the incidence of SARS–CoV‐2 testing and infection in IMID patients and non‐IMID patients. Multivariable logistic regressions assessed odds of SARS–CoV‐2 infection. Results We studied 493,499 patients with IMIDs and 2,466,946 patients without IMIDs. Patients with IMIDs were more likely to have at least 1 SARS–CoV‐2 test versus patients without IMIDs (27.4% versus 22.7%), but the proportion testing positive for SARS–CoV‐2 was identical (0.9% in both groups). Overall, IMID patients had 20% higher odds of being tested for SARS–CoV‐2 (odds ratio 1.20 [95% confidence interval 1.19–1.21]). The odds of SARS–CoV‐2 infection varied across IMID groups but was not significantly elevated for most IMID groups compared with non‐IMID comparators. The odds of SARS–CoV‐2 infection was lower in IBD and MS and marginally higher in RA and iritis. Conclusion Patients across all IMIDs were more likely to be tested for SARS–CoV‐2 versus those without IMIDs. The risk of SARS–CoV‐2 infection varied across disease subgroups." @default.
• W3198616971 created "2021-09-13" @default.
• W3198616971 creator A5001830614 @default.
• W3198616971 creator A5003819915 @default.
• W3198616971 creator A5009722499 @default.
• W3198616971 creator A5028935397 @default.
• W3198616971 creator A5031795110 @default.
• W3198616971 creator A5042922893 @default.
• W3198616971 creator A5044307132 @default.
• W3198616971 creator A5052911433 @default.
• W3198616971 creator A5054553011 @default.
• W3198616971 creator A5062221266 @default.
• W3198616971 creator A5072933348 @default.
• W3198616971 date "2022-09-27" @default.
• W3198616971 modified "2023-09-26" @default.
• W3198616971 title "Understanding <scp>COVID</scp>‐19 Risk in Patients With <scp>Immune‐Mediated</scp> Inflammatory Diseases: A <scp>Population‐Based</scp> Analysis of <scp>SARS</scp>–<scp>CoV</scp>‐2 Testing" @default.
• W3198616971 cites W1988510033 @default.
• W3198616971 cites W1997707290 @default.
• W3198616971 cites W2020215020 @default.
• W3198616971 cites W2036668944 @default.
• W3198616971 cites W2133026748 @default.
• W3198616971 cites W2142739531 @default.
• W3198616971 cites W2570121183 @default.
• W3198616971 cites W2608332984 @default.
• W3198616971 cites W2911416074 @default.
• W3198616971 cites W2932105152 @default.
• W3198616971 cites W3006217462 @default.
• W3198616971 cites W3011047976 @default.
• W3198616971 cites W3014697832 @default.
• W3198616971 cites W3021115216 @default.
• W3198616971 cites W3022606024 @default.
• W3198616971 cites W3024591296 @default.
• W3198616971 cites W3025283885 @default.
• W3198616971 cites W3032175458 @default.
• W3198616971 cites W3033241462 @default.
• W3198616971 cites W3038582169 @default.
• W3198616971 cites W3043867802 @default.
• W3198616971 cites W3044399730 @default.
• W3198616971 cites W3089261823 @default.
• W3198616971 cites W3092151577 @default.
• W3198616971 cites W3092279220 @default.
• W3198616971 cites W3093084901 @default.
• W3198616971 cites W3097732970 @default.
• W3198616971 cites W3098620210 @default.
• W3198616971 cites W3111560915 @default.
• W3198616971 cites W3115012522 @default.
• W3198616971 cites W3137569959 @default.
• W3198616971 cites W3158770594 @default.
• W3198616971 cites W4206041650 @default.
• W3198616971 doi "https://doi.org/10.1002/acr.24781" @default.
• W3198616971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34486829" @default.
• W3198616971 hasPublicationYear "2022" @default.
• W3198616971 type Work @default.
• W3198616971 sameAs 3198616971 @default.
• W3198616971 citedByCount "9" @default.
• W3198616971 countsByYear W31986169712022 @default.
• W3198616971 countsByYear W31986169712023 @default.
• W3198616971 crossrefType "journal-article" @default.
• W3198616971 hasAuthorship W3198616971A5001830614 @default.
• W3198616971 hasAuthorship W3198616971A5003819915 @default.
• W3198616971 hasAuthorship W3198616971A5009722499 @default.
• W3198616971 hasAuthorship W3198616971A5028935397 @default.
• W3198616971 hasAuthorship W3198616971A5031795110 @default.
• W3198616971 hasAuthorship W3198616971A5042922893 @default.
• W3198616971 hasAuthorship W3198616971A5044307132 @default.
• W3198616971 hasAuthorship W3198616971A5052911433 @default.
• W3198616971 hasAuthorship W3198616971A5054553011 @default.
• W3198616971 hasAuthorship W3198616971A5062221266 @default.
• W3198616971 hasAuthorship W3198616971A5072933348 @default.
• W3198616971 hasBestOaLocation W31986169711 @default.
• W3198616971 hasConcept C120665830 @default.
• W3198616971 hasConcept C121332964 @default.
• W3198616971 hasConcept C126322002 @default.
• W3198616971 hasConcept C156957248 @default.
• W3198616971 hasConcept C203014093 @default.
• W3198616971 hasConcept C2776260265 @default.
• W3198616971 hasConcept C2777402515 @default.
• W3198616971 hasConcept C2777575956 @default.
• W3198616971 hasConcept C2908647359 @default.
• W3198616971 hasConcept C44249647 @default.
• W3198616971 hasConcept C61511704 @default.
• W3198616971 hasConcept C71924100 @default.
• W3198616971 hasConcept C72563966 @default.
• W3198616971 hasConcept C99454951 @default.
• W3198616971 hasConceptScore W3198616971C120665830 @default.
• W3198616971 hasConceptScore W3198616971C121332964 @default.
• W3198616971 hasConceptScore W3198616971C126322002 @default.
• W3198616971 hasConceptScore W3198616971C156957248 @default.
• W3198616971 hasConceptScore W3198616971C203014093 @default.
• W3198616971 hasConceptScore W3198616971C2776260265 @default.
• W3198616971 hasConceptScore W3198616971C2777402515 @default.
• W3198616971 hasConceptScore W3198616971C2777575956 @default.
• W3198616971 hasConceptScore W3198616971C2908647359 @default.
• W3198616971 hasConceptScore W3198616971C44249647 @default.
• W3198616971 hasConceptScore W3198616971C61511704 @default.
• W3198616971 hasConceptScore W3198616971C71924100 @default.
• W3198616971 hasConceptScore W3198616971C72563966 @default.
• W3198616971 hasConceptScore W3198616971C99454951 @default.

• next